Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cornea | 33 | 2025 | 70 | 4.540 |
Why?
|
| Keratoconus | 16 | 2025 | 18 | 3.620 |
Why?
|
| Corneal Topography | 25 | 2025 | 27 | 2.870 |
Why?
|
| Myopia | 14 | 2023 | 27 | 2.310 |
Why?
|
| Visual Acuity | 22 | 2025 | 111 | 2.230 |
Why?
|
| Refractive Errors | 13 | 2022 | 28 | 2.170 |
Why?
|
| Down Syndrome | 9 | 2022 | 32 | 2.000 |
Why?
|
| Vision Screening | 6 | 2022 | 21 | 1.660 |
Why?
|
| Vision Disorders | 5 | 2020 | 61 | 1.200 |
Why?
|
| Anterior Chamber | 5 | 2020 | 12 | 1.130 |
Why?
|
| Lasers, Excimer | 6 | 2023 | 7 | 1.110 |
Why?
|
| Photorefractive Keratectomy | 5 | 2023 | 6 | 1.090 |
Why?
|
| Refraction, Ocular | 17 | 2023 | 48 | 1.030 |
Why?
|
| Photochemotherapy | 6 | 2023 | 43 | 0.920 |
Why?
|
| Iran | 27 | 2025 | 202 | 0.900 |
Why?
|
| Lens Implantation, Intraocular | 3 | 2015 | 16 | 0.870 |
Why?
|
| Phacoemulsification | 3 | 2015 | 19 | 0.860 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2025 | 94 | 0.850 |
Why?
|
| Astigmatism | 6 | 2021 | 16 | 0.850 |
Why?
|
| Cross-Linking Reagents | 7 | 2023 | 51 | 0.790 |
Why?
|
| Humans | 78 | 2025 | 43102 | 0.710 |
Why?
|
| Evaluation Studies as Topic | 1 | 2020 | 62 | 0.660 |
Why?
|
| Keratomileusis, Laser In Situ | 3 | 2023 | 4 | 0.660 |
Why?
|
| Academies and Institutes | 1 | 2020 | 39 | 0.650 |
Why?
|
| Riboflavin | 6 | 2022 | 24 | 0.650 |
Why?
|
| Eyeglasses | 3 | 2016 | 22 | 0.650 |
Why?
|
| Male | 54 | 2025 | 23409 | 0.650 |
Why?
|
| Female | 57 | 2025 | 24698 | 0.640 |
Why?
|
| Adult | 45 | 2025 | 13872 | 0.640 |
Why?
|
| Universities | 2 | 2020 | 559 | 0.630 |
Why?
|
| Alkylating Agents | 3 | 2015 | 14 | 0.630 |
Why?
|
| Mitomycin | 3 | 2015 | 13 | 0.630 |
Why?
|
| Prospective Studies | 17 | 2022 | 1600 | 0.600 |
Why?
|
| Cataract Extraction | 5 | 2025 | 23 | 0.580 |
Why?
|
| Hyperopia | 5 | 2019 | 7 | 0.560 |
Why?
|
| Young Adult | 23 | 2025 | 5080 | 0.540 |
Why?
|
| Amblyopia | 4 | 2019 | 13 | 0.520 |
Why?
|
| Middle Aged | 34 | 2025 | 12222 | 0.500 |
Why?
|
| Tears | 2 | 2014 | 11 | 0.500 |
Why?
|
| Patient Education as Topic | 1 | 2018 | 235 | 0.500 |
Why?
|
| Schools | 1 | 2018 | 283 | 0.490 |
Why?
|
| Endothelium, Corneal | 3 | 2020 | 8 | 0.490 |
Why?
|
| Minority Groups | 2 | 2023 | 690 | 0.480 |
Why?
|
| Aniridia | 1 | 2015 | 2 | 0.480 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 16 | 0.480 |
Why?
|
| Albinism, Oculocutaneous | 1 | 2015 | 6 | 0.470 |
Why?
|
| Prostheses and Implants | 1 | 2015 | 18 | 0.470 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 5 | 2017 | 14 | 0.470 |
Why?
|
| Photosensitizing Agents | 7 | 2023 | 56 | 0.460 |
Why?
|
| Pseudophakia | 2 | 2012 | 3 | 0.420 |
Why?
|
| Refractometry | 1 | 2014 | 16 | 0.420 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 497 | 0.410 |
Why?
|
| Child | 15 | 2022 | 3443 | 0.410 |
Why?
|
| Photography | 3 | 2011 | 50 | 0.400 |
Why?
|
| Aging | 8 | 2022 | 783 | 0.390 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 310 | 0.390 |
Why?
|
| Adolescent | 21 | 2021 | 6081 | 0.370 |
Why?
|
| Cross-Sectional Studies | 20 | 2020 | 3156 | 0.360 |
Why?
|
| Follow-Up Studies | 10 | 2025 | 1067 | 0.340 |
Why?
|
| Collagen | 4 | 2022 | 181 | 0.330 |
Why?
|
| Child, Preschool | 7 | 2022 | 1546 | 0.330 |
Why?
|
| Pupil | 3 | 2020 | 9 | 0.320 |
Why?
|
| Lenses, Intraocular | 1 | 2010 | 25 | 0.310 |
Why?
|
| Descemet Membrane | 1 | 2009 | 2 | 0.300 |
Why?
|
| Corneal Transplantation | 1 | 2009 | 2 | 0.300 |
Why?
|
| Corneal Diseases | 2 | 2024 | 11 | 0.300 |
Why?
|
| Intraoperative Complications | 1 | 2009 | 20 | 0.290 |
Why?
|
| Prevalence | 11 | 2022 | 1612 | 0.280 |
Why?
|
| Retrospective Studies | 8 | 2025 | 2544 | 0.280 |
Why?
|
| Corneal Surgery, Laser | 1 | 2007 | 1 | 0.270 |
Why?
|
| Contrast Sensitivity | 4 | 2018 | 34 | 0.270 |
Why?
|
| Aged | 14 | 2025 | 8214 | 0.270 |
Why?
|
| Reproducibility of Results | 7 | 2016 | 1081 | 0.250 |
Why?
|
| Biomedical Research | 2 | 2023 | 502 | 0.250 |
Why?
|
| Incidence | 5 | 2025 | 1078 | 0.240 |
Why?
|
| Strabismus | 2 | 2016 | 18 | 0.240 |
Why?
|
| Retinoscopy | 4 | 2021 | 11 | 0.240 |
Why?
|
| Postoperative Period | 4 | 2015 | 33 | 0.240 |
Why?
|
| Students | 2 | 2023 | 626 | 0.240 |
Why?
|
| Reoperation | 1 | 2025 | 34 | 0.240 |
Why?
|
| Sensitivity and Specificity | 2 | 2025 | 611 | 0.230 |
Why?
|
| Reference Values | 6 | 2020 | 211 | 0.220 |
Why?
|
| Anisometropia | 2 | 2021 | 3 | 0.220 |
Why?
|
| Los Angeles | 4 | 2022 | 394 | 0.220 |
Why?
|
| Dry Eye Syndromes | 2 | 2014 | 6 | 0.210 |
Why?
|
| Age Distribution | 7 | 2016 | 249 | 0.210 |
Why?
|
| Light | 2 | 2018 | 185 | 0.200 |
Why?
|
| Postoperative Complications | 1 | 2025 | 263 | 0.200 |
Why?
|
| Corneal Dystrophy, Juvenile Epithelial of Meesmann | 1 | 2023 | 1 | 0.200 |
Why?
|
| Intraocular Pressure | 3 | 2020 | 132 | 0.200 |
Why?
|
| Aged, 80 and over | 7 | 2025 | 2853 | 0.200 |
Why?
|
| Nomograms | 1 | 2022 | 14 | 0.190 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 112 | 0.180 |
Why?
|
| Glare | 3 | 2017 | 4 | 0.180 |
Why?
|
| Vaccines | 1 | 2022 | 65 | 0.170 |
Why?
|
| Health Status Disparities | 2 | 2022 | 719 | 0.170 |
Why?
|
| Cohort Studies | 7 | 2022 | 1759 | 0.170 |
Why?
|
| Sex Distribution | 5 | 2016 | 224 | 0.170 |
Why?
|
| Benchmarking | 1 | 2020 | 32 | 0.170 |
Why?
|
| Government Programs | 1 | 2020 | 29 | 0.160 |
Why?
|
| Corneal Endothelial Cell Loss | 1 | 2020 | 1 | 0.160 |
Why?
|
| Basic Reproduction Number | 1 | 2020 | 2 | 0.160 |
Why?
|
| Corneal Stroma | 3 | 2018 | 6 | 0.160 |
Why?
|
| Health Services Needs and Demand | 3 | 2016 | 154 | 0.160 |
Why?
|
| Leadership | 1 | 2020 | 86 | 0.160 |
Why?
|
| Eye Diseases | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mothers | 1 | 2021 | 215 | 0.150 |
Why?
|
| Tonometry, Ocular | 2 | 2016 | 27 | 0.150 |
Why?
|
| Polypharmacy | 1 | 2019 | 27 | 0.150 |
Why?
|
| Physician's Role | 1 | 2019 | 40 | 0.150 |
Why?
|
| Night Vision | 1 | 2018 | 3 | 0.150 |
Why?
|
| Cultural Diversity | 1 | 2020 | 193 | 0.150 |
Why?
|
| Ultraviolet Rays | 4 | 2022 | 118 | 0.150 |
Why?
|
| Color Vision | 1 | 2018 | 10 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 83 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 88 | 0.140 |
Why?
|
| Elasticity | 2 | 2017 | 53 | 0.140 |
Why?
|
| Population Surveillance | 1 | 2019 | 246 | 0.140 |
Why?
|
| Anterior Eye Segment | 2 | 2019 | 9 | 0.140 |
Why?
|
| Time Factors | 6 | 2019 | 1857 | 0.140 |
Why?
|
| Diabetes Complications | 1 | 2018 | 102 | 0.140 |
Why?
|
| Ultrasonics | 2 | 2007 | 15 | 0.140 |
Why?
|
| Self Medication | 1 | 2017 | 13 | 0.130 |
Why?
|
| Blindness | 1 | 2016 | 19 | 0.130 |
Why?
|
| Vision, Low | 1 | 2016 | 13 | 0.130 |
Why?
|
| Convergence, Ocular | 1 | 2016 | 3 | 0.130 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 173 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 590 | 0.120 |
Why?
|
| Public Health | 1 | 2021 | 424 | 0.120 |
Why?
|
| Cataract | 3 | 2015 | 47 | 0.120 |
Why?
|
| Physical Examination | 1 | 2016 | 45 | 0.120 |
Why?
|
| Eye Movements | 1 | 2015 | 16 | 0.120 |
Why?
|
| Ophthalmology | 1 | 2016 | 34 | 0.120 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 76 | 0.120 |
Why?
|
| Caregivers | 1 | 2017 | 197 | 0.110 |
Why?
|
| Debridement | 1 | 2014 | 4 | 0.110 |
Why?
|
| Elastic Tissue | 1 | 2014 | 9 | 0.110 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 1234 | 0.110 |
Why?
|
| Color Vision Defects | 1 | 2014 | 2 | 0.110 |
Why?
|
| Solvents | 1 | 2014 | 113 | 0.100 |
Why?
|
| Risk Factors | 4 | 2025 | 3994 | 0.100 |
Why?
|
| Body Weights and Measures | 3 | 2009 | 25 | 0.100 |
Why?
|
| National Eye Institute (U.S.) | 1 | 2013 | 3 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 25 | 0.100 |
Why?
|
| Fluorophotometry | 1 | 2013 | 1 | 0.100 |
Why?
|
| Statistical Distributions | 1 | 2013 | 3 | 0.100 |
Why?
|
| Treatment Outcome | 4 | 2023 | 1604 | 0.100 |
Why?
|
| United States | 3 | 2020 | 5205 | 0.100 |
Why?
|
| Conflict of Interest | 1 | 2012 | 11 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 539 | 0.100 |
Why?
|
| Editorial Policies | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bibliometrics | 1 | 2012 | 16 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2011 | 135 | 0.100 |
Why?
|
| Postoperative Care | 1 | 2012 | 20 | 0.090 |
Why?
|
| Presbyopia | 1 | 2012 | 1 | 0.090 |
Why?
|
| Disclosure | 1 | 2012 | 39 | 0.090 |
Why?
|
| Double-Blind Method | 1 | 2013 | 317 | 0.090 |
Why?
|
| Periodicals as Topic | 1 | 2012 | 52 | 0.090 |
Why?
|
| Ethanol | 1 | 2014 | 224 | 0.090 |
Why?
|
| Glaucoma | 1 | 2013 | 100 | 0.090 |
Why?
|
| Sex Factors | 5 | 2014 | 1028 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 165 | 0.090 |
Why?
|
| Aberrometry | 1 | 2010 | 1 | 0.080 |
Why?
|
| Acrylic Resins | 1 | 2010 | 13 | 0.080 |
Why?
|
| Comorbidity | 1 | 2013 | 737 | 0.080 |
Why?
|
| Fovea Centralis | 1 | 2010 | 3 | 0.080 |
Why?
|
| Menstrual Cycle | 1 | 2010 | 36 | 0.080 |
Why?
|
| Age Factors | 3 | 2019 | 1154 | 0.080 |
Why?
|
| Iris | 1 | 2009 | 11 | 0.080 |
Why?
|
| Fuchs' Endothelial Dystrophy | 1 | 2009 | 2 | 0.080 |
Why?
|
| Automation | 1 | 2009 | 22 | 0.070 |
Why?
|
| Quality of Life | 1 | 2013 | 616 | 0.070 |
Why?
|
| Contact Lenses, Hydrophilic | 1 | 2008 | 2 | 0.070 |
Why?
|
| Preoperative Care | 1 | 2007 | 32 | 0.070 |
Why?
|
| Disease Progression | 2 | 2022 | 667 | 0.060 |
Why?
|
| Population Groups | 3 | 2013 | 59 | 0.060 |
Why?
|
| Interferometry | 1 | 2005 | 3 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2005 | 22 | 0.060 |
Why?
|
| Corneal Wavefront Aberration | 2 | 2018 | 2 | 0.060 |
Why?
|
| Educational Status | 2 | 2020 | 339 | 0.060 |
Why?
|
| Qualitative Research | 2 | 2019 | 574 | 0.060 |
Why?
|
| Entrepreneurship | 1 | 2023 | 5 | 0.050 |
Why?
|
| Mydriatics | 1 | 2022 | 6 | 0.050 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2022 | 5 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2024 | 341 | 0.050 |
Why?
|
| Urban Population | 2 | 2015 | 374 | 0.050 |
Why?
|
| Dilatation, Pathologic | 1 | 2021 | 10 | 0.050 |
Why?
|
| ROC Curve | 1 | 2022 | 159 | 0.040 |
Why?
|
| Health Surveys | 2 | 2015 | 405 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2020 | 25 | 0.040 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2019 | 1 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 110 | 0.040 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 38 | 0.040 |
Why?
|
| Eyelid Diseases | 1 | 2019 | 5 | 0.040 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2020 | 120 | 0.040 |
Why?
|
| Vaccination | 1 | 2022 | 355 | 0.040 |
Why?
|
| Income | 1 | 2020 | 160 | 0.040 |
Why?
|
| Hospitalization | 1 | 2022 | 485 | 0.040 |
Why?
|
| Linear Models | 2 | 2009 | 317 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 145 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 712 | 0.030 |
Why?
|
| Esotropia | 1 | 2016 | 3 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2017 | 178 | 0.030 |
Why?
|
| Vision Tests | 1 | 2015 | 5 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 231 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 638 | 0.030 |
Why?
|
| Intraoperative Period | 1 | 2014 | 3 | 0.030 |
Why?
|
| Biometry | 1 | 2014 | 34 | 0.030 |
Why?
|
| Refractive Surgical Procedures | 1 | 2014 | 1 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2014 | 9 | 0.030 |
Why?
|
| Cell Count | 1 | 2014 | 145 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2014 | 224 | 0.030 |
Why?
|
| Rose Bengal | 1 | 2013 | 3 | 0.030 |
Why?
|
| Fluorescein | 1 | 2013 | 18 | 0.030 |
Why?
|
| Dark Adaptation | 1 | 2013 | 17 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2013 | 107 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1063 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 182 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 373 | 0.020 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 2 | 0.020 |
Why?
|
| Tomography, Optical Coherence | 1 | 2010 | 38 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 989 | 0.020 |
Why?
|
| Anisocoria | 1 | 2009 | 1 | 0.020 |
Why?
|
| Eye Color | 1 | 2009 | 3 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 162 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 123 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2013 | 925 | 0.020 |
Why?
|